---
id: fever-rash-emergency_271
category: clinical-syndromes
tags: [fever, rash, petechiae, meningococcemia, RMSF, toxic-shock-syndrome, emergency]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Acutely Ill Patient With Fever and Rash: Life-Threatening Causes

**Q:** What are the life-threatening causes of fever + rash in acutely ill patients, and what are the key distinguishing features?

**A:**

| Condition | Rash Characteristics | Distribution | Timeline | Additional Features |
|-----------|---------------------|--------------|----------|---------------------|
| **Meningococcemia** (*N. meningitidis*) | Petechiae → palpable purpura with **gunmetal gray necrotic centers** | Trunk, extremities | Present in only 60% at initial presentation | Shock, coagulopathy (DIC), ± meningismus |
| **RMSF** (*R. rickettsii*) | Maculopapular → petechiae/purpura | **Wrists/ankles → palms/soles** (centripetal spread) | Day 4 (only <50% have rash in first 3 days) | **Tick exposure**, headache, edema |
| **Staphylococcal TSS** | Diffuse **erythroderma** ("sunburn") → **desquamation** (1-2 weeks) | Generalized, includes palms/soles | Rapid onset | Shock, ↓ BP, multi-organ dysfunction, ± tampon/wound |
| **Streptococcal TSS** (GAS) | Variable: erythema, purpura, or necrotizing fasciitis | Variable | Rapid progression | Soft tissue infection, shock, multi-organ failure |

**Key Principles:**
- **Fever + petechiae = emergent evaluation** for meningococcemia/RMSF
- **Both begin maculopapular** before becoming petechial
- **Empiric treatment BEFORE confirmatory testing** (blood cultures, PCR, serology)

**Initial Management:**
- Meningococcemia: **Ceftriaxone 2 g IV** + droplet precautions
- RMSF: **Doxycycline 100 mg IV BID** (regardless of age)
- TSS: **Clindamycin 900 mg IV q8h** (toxin suppression) + source control

**Media:**

**Sources:** [Mayo Clin Proc Life-Threatening Rashes], [ScienceDirect Rash & Fever in Critical Care], [emDocs Dangerous Rashes], [Contemporary Pediatrics Rash & Fever Emergency]
